Apoptosis and necrosis in vaccinia virus-infected HeLa G and BSC-40 cells

Virus Research

Volumn 160, Issue 1-2, 2011, Pages 40-50

  Liskova, Jana ^a   Knitlova, Jarmila ^a   Honner, Richard ^a   Melkova, Zora ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Caspases; Dryvax; Praha; Vaccinia virus; Western Reserve

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SMALLPOX VACCINE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EPITHELIUM CELL; HELA CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; CASPASES; CELL DEATH; CELL LINE; CERCOPITHECUS AETHIOPS; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; VACCINIA VIRUS;

VACCINIA VIRUS;

EID: 80052155244     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.05.005     Document Type: Article

References (61)

1. Alcami A. New insights into the subversion of the chemokine system by poxviruses. Eur. J. Immunol. 2007, 37(4):880-883.
2. Aragon T.J., Ulrich S., Fernyak S., Rutherford G.W. Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968. BMC Public Health 2003, 3:26.
3. Baixeras E., Cebrian A., Albar J.P., Salas J., Martinez A.C., Vinuela E., Revilla Y. Vaccinia virus-induced apoptosis in immature B lymphocytes: role of cellular Bcl-2. Virus Res. 1998, 58(1-2):107-113.
4. Bouchier-Hayes L. The role of caspase-2 in stress-induced apoptosis. J. Cell. Mol. Med. 2010, 14(6A):1212-1224.
5. Carrasco L., Esteban M. Modification of membrane permeability in vaccinia virus-infected cells. Virology 1982, 117(1):62-69.
6. Cassens U., Lewinski G., Samraj A.K., von Bernuth H., Baust H., Khazaie K., Los M. Viral modulation of cell death by inhibition of caspases. Arch. Immunol. Ther. Exp. (Warsz) 2003, 51(1):19-27.
7. Caulin C., Salvesen G.S., Oshima R.G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 1997, 138(6):1379-1394.
8. Cooray S., Bahar M.W., Abrescia N.G., McVey C.E., Bartlett N.W., Chen R.A., Stuart D.I., Grimes J.M., Smith G.L. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J. Gen. Virol. 2007, 88(Pt 6):1656-1666.
9. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116(2):205-219.
10. Davies D.H., Wyatt L.S., Newman F.K., Earl P.L., Chun S., Hernandez J.E., Molina D.M., Hirst S., Moss B., Frey S.E., Felgner P.L. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J. Virol. 2008, 82(2):652-663.
11. Davies M.V., Chang H.W., Jacobs B.L., Kaufman R.J. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 1993, 67(3):1688-1692.
12. Degterev A., Yuan J. Expansion and evolution of cell death programmes. Nat. Rev. Mol Cell Biol. 2008, 9(5):378-390.
13. Dobbelstein M., Shenk T. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J. Virol. 1996, 70(9):6479-6485.
14. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999, 163(12):6762-6768.
15. Fujikura Y., Kudlackova P., Vokurka M., Krijt J., Melkova Z. The effect of nitric oxide on vaccinia virus-encoded ribonucleotide reductase. Nitric Oxide 2009, 20(2):114-121.
16. Golstein P., Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 2007, 32(1):37-43.
17. Green D.R., Ferguson T., Zitvogel L., Kroemer G. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 2009, 9(5):353-363.
18. Harlow E., Lane D. Immunoblotting. Antibodies: A Laboratory Manual 1988, 471-510. Cold Spring Harbor Laboratory Press, New York. E. Harlow, D. Lane (Eds.).
19. Humlova Z., Vokurka M., Esteban M., Melkova Z. Vaccinia virus induces apoptosis of infected macrophages. J. Gen. Virol. 2002, 83(Pt 11):2821-2832.
20. Joklik W.K. The purification of four strains of poxvirus. Virology 1962, 18:9-18.
21. Kalbacova M. Effects of Bcl-2 Expression by Vaccinia Virus on Cell Metabolism and Apoptosis 2003, Charles University.
22. Kalbacova M., Spisakova M., Liskova J., Melkova Z. Lytic infection with vaccinia virus activates caspases in a Bcl-2-inhibitable manner. Virus Res. 2008, 135(1):53-63.
23. Kalbacova M., Vrbacky M., Drahota Z., Melkova Z. Comparison of the effect of mitochondrial inhibitors on mitochondrial membrane potential in two different cell lines using flow cytometry and spectrofluorometry. Cytometry A 2003, 52(2):110-116.
24. Kalbacova M., Vrbacky M., Humlova Z., Melkova Z. Protooncogene Bcl-2 induces apoptosis in several cell lines. Folia Biol. (Praha) 2002, 48(1):15-27.
25. Kepp O., Senovilla L., Galluzzi L., Panaretakis T., Tesniere A., Schlemmer F., Madeo F., Zitvogel L., Kroemer G. Viral subversion of immunogenic cell death. Cell Cycle 2009, 8(6):860-869.
26. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26(4):239-257.
27. Kibler K.V., Shors T., Perkins K.B., Zeman C.C., Banaszak M.P., Biesterfeldt J., Langland J.O., Jacobs B.L. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 1997, 71(3):1992-2003.
28. Kotwal G.J., Hugin A.W., Moss B. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 1989, 171(2):579-587.
29. Kotwal G.J., Moss B. Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J. Virol. 1989, 63(2):600-606.
30. Kroemer G., El-Deiry W.S., Golstein P., Peter M.E., Vaux D., Vandenabeele P., Zhivotovsky B., Blagosklonny M.V., Malorni W., Knight R.A., Piacentini M., Nagata S., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 2005, 12(Suppl. 2):1463-1467.
31. Kutinova L., Ludvikova V., Krystofova J., Otavova M., Simonova V., Nemeckova S., Hainz P., Vonka V. Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I. Vaccine 1996, 14(11):1045-1052.
32. Kutinova L., Ludvikova V., Simonova V., Otavova M., Krystofova J., Hainz P., Press M., Kunke D., Vonka V. Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine 1995, 13(5):487-493.
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
34. Lee S.B., Esteban M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 1994, 199(2):491-496.
35. Linder S., Havelka A.M., Ueno T., Shoshan M.C. Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett. 2004, 214(1):1-9.
36. Lizard G., Deckert V., Dubrez L., Moisant M., Gambert P., Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am. J. Pathol. 1996, 148(5):1625-1638.
37. Macen J., Takahashi A., Moon K.B., Nathaniel R., Turner P.C., Moyer R.W. Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses. J. Virol. 1998, 72(5):3524-3533.
38. Majai G., Petrovski G., Fesus L. Inflammation and the apopto-phagocytic system. Immunol. Lett. 2006, 104(1-2):94-101.
39. Marques J.T., Rebouillat D., Ramana C.V., Murakami J., Hill J.E., Gudkov A., Silverman R.H., Stark G.R., Williams B.R. Down-regulation of p53 by double-stranded RNA modulates the antiviral response. J. Virol. 2005, 79(17):11105-11114.
40. Martinon F., Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007, 14(1):10-22.
41. Osborne J.D., Da Silva M., Frace A.M., Sammons S.A., Olsen-Rasmussen M., Upton C., Buller R.M., Chen N., Feng Z., Roper R.L., Liu J., Pougatcheva S., Chen W., Wohlhueter R.M., Esposito J.J. Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3. Vaccine 2007, 25(52):8807-8832.
42. Ramsey-Ewing A., Moss B. Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells. Virology 1998, 242(1):138-149.
43. Rivas C., Gil J., Melkova Z., Esteban M., Diaz-Guerra M. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 1998, 243(2):406-414.
44. Rodriguez J.F., Rodriguez D., Rodriguez J.R., McGowan E.B., Esteban M. Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc. Natl. Acad. Sci. U.S.A. 1988, 85(5):1667-1671.
45. Romano P.R., Zhang F., Tan S.L., Garcia-Barrio M.T., Katze M.G., Dever T.E., Hinnebusch A.G. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell Biol. 1998, 18(12):7304-7316.
46. Santos C.R., Vega F.M., Blanco S., Barcia R., Lazo P.A. The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism. Virology 2004, 328(2):254-265.
47. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 2003, 21:377-423.
48. Schumperli D., Peterhans E., Wyler R. Permeability changes of plasma and lysosomal membranes in HeLa cells infected with rabbit poxvirus. Arch. Virol. 1978, 58(3):203-212.
49. Silverman G.A., Lomas D.A. Molecular and Cellular Aspects of the Serpinopathies and Disorders in Serpin Activity 2007, World Scientific Publishing Co. Pte. Ltd., Singapore.
50. Stewart T.L., Wasilenko S.T., Barry M. Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis. J. Virol. 2005, 79(2):1084-1098.
51. Taylor J.M., Barry M. Near death experiences: poxvirus regulation of apoptotic death. Virology 2006, 344(1):139-150.
52. Taylor J.M., Quilty D., Banadyga L., Barry M. The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax. J. Biol. Chem. 2006, 281(51):39728-39739.
53. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9(3):231-241.
54. Turner S.J., Silke J., Kenshole B., Ruby J. Characterization of the ectromelia virus serpin, SPI-2. J. Gen. Virol. 2000, 81(Pt 10):2425-2430.
55. Vakifahmetoglu-Norberg H., Zhivotovsky B. The unpredictable caspase-2: what can it do?. Trends Cell Biol. 2010, 20(3):150-159.
56. Vrbacky M., Krijt J., Drahota Z., Melkova Z. Inhibitory effects of Bcl-2 on mitochondrial respiration. Physiol. Res. 2003, 52(5):545-554.
57. Wali A., Strayer D.S. Infection with vaccinia virus alters regulation of cell cycle progression. DNA Cell Biol. 1999, 18(11):837-843.
58. Wasilenko S.T., Banadyga L., Bond D., Barry M. The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J. Virol. 2005, 79(22):14031-14043.
59. Wyllie A.H. "Where O death, is thy sting?" A brief review of apoptosis biology. Mol. Neurobiol. 2010, 42(1):4-9.
60. Yoo N.K., Pyo C.W., Kim Y., Ahn B.Y., Choi S.Y. Vaccinia virus-mediated cell cycle alteration involves inactivation of tumour suppressors associated with Brf1 and TBP. Cell. Microbiol. 2008, 10(3):583-592.
61. Zhai D., Yu E., Jin C., Welsh K., Shiau C.W., Chen L., Salvesen G.S., Liddington R., Reed J.C. Vaccinia virus protein F1L is a caspase-9 inhibitor. J. Biol. Chem. 2010, 285(8):5569-5580.